Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-09 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-09 |
mRNA | RCC2 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-11 |
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
mRNA | ZNF445 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |